General Statement of Disclosure:
CONSULTING FEES/HONORARIA: XyloCor(MODEST) RESEARCH/RESEARCH GRANTS: CSL Behring (SIGNIFICANT), Biocardia(SIGNIFICANT) OTHER FINANCIAL BENEFIT: Elsevier (SIGNIFICANT)
CONSULTING FEES/HONORARIA: XyloCor(MODEST) RESEARCH/RESEARCH GRANTS: CSL Behring (SIGNIFICANT), Biocardia(SIGNIFICANT) OTHER FINANCIAL BENEFIT: Elsevier (SIGNIFICANT)
© 2025 American College of Cardiology Foundation. All rights reserved.
